PHARMACEUTICAL PRODUCT DEVELOPMENT INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 469 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-12-05: Reporting owner BRYSON VAUGHN D; Form 4; Security Stock Options (to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2011-12-05: Reporting owner BONDURANT STUART; Form 4; Security Stock Options (to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2011-12-05: Reporting owner BONDURANT STUART; Form 4; Security Stock Options (to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2011-12-05: Reporting owner BONDURANT STUART; Form 4; Security Stock Options (to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-12-05 | BRYSON VAUGHN D Director | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,095 0 owned after | $28.52 exercise price | 2011-12-06 | |
| 2011-12-05 | BONDURANT STUART Director | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,095 0 owned after | $28.52 exercise price | 2011-12-06 | |
| 2011-12-05 | BONDURANT STUART Director | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,496 0 owned after | $24.52 exercise price | 2011-12-06 | |
| 2011-12-05 | BONDURANT STUART Director | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,053 0 owned after | $19.19 exercise price | 2011-12-06 | |
| 2011-12-05 | BONDURANT STUART Director | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,485 0 owned after | $41.32 exercise price | 2011-12-06 | |
| 2011-12-05 | BONDURANT STUART Director | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,341 0 owned after | $32.67 exercise price | 2011-12-06 | |
| 2011-12-05 | BONDURANT STUART Director | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,113 0 owned after | $34.18 exercise price | 2011-12-06 | |
| 2011-12-05 | BONDURANT STUART Director | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,650 0 owned after | $22.98 exercise price | 2011-12-06 | |
| 2011-12-05 | Babiss Lee Officer (Exec. VP--Global Lab Services) | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $27.27 exercise price | 2011-12-06 | |
| 2011-12-05 | Babiss Lee Officer (Exec. VP--Global Lab Services) | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $26.64 exercise price | 2011-12-06 | |
| 2011-12-05 | Babiss Lee Officer (Exec. VP--Global Lab Services) | 4 | Stock Options (to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −46,578 0 owned after | $20.45 exercise price | 2011-12-06 | |
| 2011-09-16 | Hill Raymond H Director, Officer (Chief Executive Officer) | 4 | Stock Options (to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $28.54 exercise price | 2011-09-20 | |
| 2011-07-06 holding as of filing | Wilkinson Michael O. Officer (Chief Information Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 12,485 owned after | $25.74 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Wilkinson Michael O. Officer (Chief Information Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 21,052 owned after | $20.45 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Wilkinson Michael O. Officer (Chief Information Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,000 owned after | $26.64 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Wilkinson Michael O. Officer (Chief Information Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,211 owned after | $19.94 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Wilkinson Michael O. Officer (Chief Information Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 18,632 owned after | $37.69 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Wilkinson Michael O. Officer (Chief Information Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 7,763 owned after | $43.26 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Wilkinson Michael O. Officer (Chief Information Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 62,104 owned after | $33.80 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Sharbaugh William J Officer (Chief Operating Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 45,000 owned after | $27.27 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Sharbaugh William J Officer (Chief Operating Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 30,000 owned after | $26.64 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Sharbaugh William J Officer (Chief Operating Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 62,104 owned after | $20.45 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Sharbaugh William J Officer (Chief Operating Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 62,104 owned after | $25.74 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Sharbaugh William J Officer (Chief Operating Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 27,947 owned after | $19.94 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Sharbaugh William J Officer (Chief Operating Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 27,947 owned after | $37.69 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Sharbaugh William J Officer (Chief Operating Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 62,104 owned after | $43.26 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Sharbaugh William J Officer (Chief Operating Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 77,630 owned after | $35.26 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,000 owned after | $27.27 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,000 owned after | $27.27 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,250 owned after | $26.64 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 12,939 owned after | $20.45 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 12,939 owned after | $25.74 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 7,246 owned after | $19.94 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 7,246 owned after | $37.69 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,526 owned after | $43.26 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 23,289 owned after | $32.47 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Richardson William W Officer (Sr. VP Global Bus. Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 51,753 owned after | $27.84 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Darazsdi Daniel G Officer (Chief Financial Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 45,000 owned after | $27.27 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Darazsdi Daniel G Officer (Chief Financial Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 30,000 owned after | $26.64 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Darazsdi Daniel G Officer (Chief Financial Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 62,104 owned after | $20.45 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Darazsdi Daniel G Officer (Chief Financial Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 62,104 owned after | $25.74 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Darazsdi Daniel G Officer (Chief Financial Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 23,289 owned after | $19.94 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Darazsdi Daniel G Officer (Chief Financial Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 23,289 owned after | $37.69 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Darazsdi Daniel G Officer (Chief Financial Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 46,578 owned after | $43.26 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | Darazsdi Daniel G Officer (Chief Financial Officer) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 93,156 owned after | $34.15 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 3,753 owned after | $19.94 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 11,041 owned after | $20.45 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 30,000 owned after | $27.27 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 16,000 owned after | $26.64 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,992 owned after | $25.74 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 11,386 owned after | $37.69 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,526 owned after | $43.26 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 31,052 owned after | $37.51 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 9,095 owned after | $28.52 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 9,090 owned after | $24.26 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 10,496 owned after | $24.52 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 14,053 owned after | $19.19 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 5,650 owned after | $22.98 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 4,113 owned after | $34.18 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,341 owned after | $32.67 exercise price | 2011-07-06 | |
| 2011-07-06 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,485 owned after | $41.32 exercise price | 2011-07-06 | |
| 2011-05-27 | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −326 3,753 owned after | $19.94 exercise price | 2011-05-27 | |
| 2011-05-27 | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,333 11,041 owned after | $20.45 exercise price | 2011-05-27 | |
| 2011-05-27 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 30,000 owned after | $27.27 exercise price | 2011-05-27 | |
| 2011-05-27 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 16,000 owned after | $26.64 exercise price | 2011-05-27 | |
| 2011-05-27 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,992 owned after | $25.74 exercise price | 2011-05-27 | |
| 2011-05-27 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 11,386 owned after | $37.69 exercise price | 2011-05-27 | |
| 2011-05-27 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,526 owned after | $43.26 exercise price | 2011-05-27 | |
| 2011-05-27 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 31,052 owned after | $37.51 exercise price | 2011-05-27 | |
| 2011-05-26 | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100 4,079 owned after | $19.94 exercise price | 2011-05-27 | |
| 2011-05-23 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 30,000 owned after | $27.27 exercise price | 2011-05-23 | |
| 2011-05-23 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 16,000 owned after | $26.64 exercise price | 2011-05-23 | |
| 2011-05-23 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,992 owned after | $25.74 exercise price | 2011-05-23 | |
| 2011-05-23 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 11,386 owned after | $37.69 exercise price | 2011-05-23 | |
| 2011-05-23 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 15,526 owned after | $43.26 exercise price | 2011-05-23 | |
| 2011-05-23 holding as of filing | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | Holding | 31,052 owned after | $37.51 exercise price | 2011-05-23 | |
| 2011-05-20 | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −413 4,179 owned after | $19.94 exercise price | 2011-05-23 | |
| 2011-05-20 | COLVIN PAUL Officer (EVP--Clinical Development) | 4 | Stock Options (to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −187 16,374 owned after | $20.45 exercise price | 2011-05-23 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 9,090 owned after | $24.26 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 10,496 owned after | $24.52 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 14,053 owned after | $19.19 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,485 owned after | $41.32 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,341 owned after | $32.67 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 12,421 owned after | $12.37 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 16,561 owned after | $13.12 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 16,561 owned after | $15.28 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 5,650 owned after | $22.98 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MAGNUSON TERRY Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 4,113 owned after | $34.18 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 9,090 owned after | $24.26 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 10,496 owned after | $24.52 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 14,053 owned after | $19.19 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 5,650 owned after | $22.98 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 4,113 owned after | $34.18 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,341 owned after | $32.67 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | MARIO ERNEST Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,485 owned after | $41.32 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | FRANK FRED Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 9,090 owned after | $24.26 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | FRANK FRED Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 10,496 owned after | $24.52 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | FRANK FRED Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 14,053 owned after | $19.19 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | FRANK FRED Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,485 owned after | $41.32 exercise price | 2011-05-19 | |
| 2011-05-19 holding as of filing | FRANK FRED Director | 4 | Stock Options (to buy) Derivative · Direct | Holding | 6,341 owned after | $32.67 exercise price | 2011-05-19 |